BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 33528537)

  • 21. Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study.
    Kunz A; Ebinger M; Geisler F; Rozanski M; Waldschmidt C; Weber JE; Wendt M; Winter B; Zieschang K; Fiebach JB; Villringer K; Erdur H; Scheitz JF; Tütüncü S; Bollweg K; Grittner U; Kaczmarek S; Endres M; Nolte CH; Audebert HJ
    Lancet Neurol; 2016 Sep; 15(10):1035-43. PubMed ID: 27430529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysis.
    Turc G; Hadziahmetovic M; Walter S; Churilov L; Larsen K; Grotta JC; Yamal JM; Bowry R; Katsanos AH; Zhao H; Donnan G; Davis SM; Hussain MS; Uchino K; Helwig SA; Johns H; Weber JE; Nolte CH; Kunz A; Steiner T; Sacco S; Ebinger M; Tsivgoulis G; Faßbender K; Audebert HJ
    JAMA Neurol; 2022 Mar; 79(3):281-290. PubMed ID: 35129584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does large vessel occlusion affect clinical outcome in stroke with mild neurologic deficits after intravenous thrombolysis?
    Zhu W; Churilov L; Campbell BCV; Lin M; Liu X; Davis SM; Yan B
    J Stroke Cerebrovasc Dis; 2014; 23(10):2888-2893. PubMed ID: 25440367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
    Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
    BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Admission Leukocyte Count with Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator.
    Chen J; Zhang FL; Lv S; Jin H; Luo Y; Qu Y; Guo ZN; Yang Y
    Curr Neurovasc Res; 2020; 17(5):660-666. PubMed ID: 33243121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
    Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
    Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an Enhanced Paramedic Acute Stroke Treatment Assessment on Thrombolysis Delivery During Emergency Stroke Care: A Cluster Randomized Clinical Trial.
    Price CI; Shaw L; Islam S; Javanbakht M; Watkins A; McMeekin P; Snooks H; Flynn D; Francis R; Lakey R; Sutcliffe L; McClelland G; Lally J; Exley C; Rodgers H; Russell I; Vale L; Ford GA
    JAMA Neurol; 2020 Jul; 77(7):840-848. PubMed ID: 32282015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobile Stroke Units in Acute Ischemic Stroke: A Comprehensive Systematic Review and Meta-Analysis of 5 "T Letter" Domains.
    Hagrass AI; Elsayed SM; Doheim MF; Mostafa MA; Elfil M; Al-Kafarna M; Almaghary BK; Fayoud AM; Hamdallah A; Hasan MT; Ragab KM; Nourelden AZ; Zaazouee MS; Medicherla C; Lerario M; Czap AL; Chong J; Nour M; Al-Mufti F
    Cardiol Rev; 2024 Jul-Aug 01; 32(4):297-313. PubMed ID: 38602410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic Evaluation of a Mobile Stroke Unit Service in Germany.
    Oliveira Gonçalves AS; Rohmann JL; Piccininni M; Kurth T; Ebinger M; Endres M; Freitag E; Harmel P; Lorenz-Meyer I; Rohrpasser-Napierkowski I; Busse R; Audebert HJ
    Ann Neurol; 2023 May; 93(5):942-951. PubMed ID: 36637359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Patients Receiving Thrombolysis in a Mobile Stroke Unit: A 4-Year Retrospective, Observational, Single-Center Study.
    Shownkeen H; Richards CT; Buffo K; Graham S; Iacob T; Mohajer-Esfahani M; Lindstrom A; Garg A; Gutti P; Sachdeva K; Shrivastava A; Williams J; Crumlett H; Huml J
    Prehosp Emerg Care; 2023; 27(5):652-658. PubMed ID: 36357362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database.
    Nagel S; Wang X; Carcel C; Robinson T; Lindley RI; Chalmers J; Anderson CS;
    Stroke; 2018 Jun; 49(6):1407-1411. PubMed ID: 29777016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Effects of Time to Initiation of Therapy on Disability and Quality of Life in Patients With Mild and Moderate to Severe Ischemic Stroke.
    Askew RL; Capo-Lugo CE; Naidech A; Prabhakaran S
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1515-1522.e1. PubMed ID: 32450061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between the B-type Natriuretic Peptide before thrombolysis and prognosis in patients with ischemic stroke.
    Pan H; Feng K; Fu M; Ge W; Zhou C
    Clin Neurol Neurosurg; 2021 Dec; 211():107021. PubMed ID: 34808477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobile stroke care expedites intravenous thrombolysis and endovascular thrombectomy.
    Bender MT; Mattingly TK; Rahmani R; Proper D; Burnett WA; Burgett JL; LEsperance J; Cushman JT; Pilcher WH; Benesch CG; Kelly AG; Bhalla T
    Stroke Vasc Neurol; 2022 Jun; 7(3):209-214. PubMed ID: 34952889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute revascularization treatments for ischemic stroke in the Stroke Units of Triveneto, northeast Italy: time to treatment and functional outcomes.
    Cappellari M; Bonetti B; Forlivesi S; Sajeva G; Naccarato M; Caruso P; Lorenzut S; Merlino G; Viaro F; Pieroni A; Giometto B; Bignamini V; Perini F; De Boni A; Morra M; Critelli A; Tamborino C; Tonello S; Guidoni SV; L'Erario R; Russo M; Burlina A; Turinese E; Passadore P; Zanet L; Polo A; Turazzini M; Basile AM; Atzori M; Marini B; Bruno M; Carella S; Campagnaro A; Baldi A; Corazza E; Zanette G; Idone D; Gaudenzi A; Bombardi R; Cadaldini M; Lanzafame S; Ferracci F; Zambito S; Ruzza G; Simonetto M; Menegazzo E; Masato M; Padoan R; Bozzato G; Paladin F; Tonon A; Bovi P
    J Thromb Thrombolysis; 2021 Jan; 51(1):159-167. PubMed ID: 32424778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency, Predictors, and Outcomes of Prehospital and Early Postarrival Neurological Deterioration in Acute Stroke: Exploratory Analysis of the FAST-MAG Randomized Clinical Trial.
    Shkirkova K; Saver JL; Starkman S; Wong G; Weng J; Hamilton S; Liebeskind DS; Eckstein M; Stratton S; Pratt F; Conwit R; Sanossian N;
    JAMA Neurol; 2018 Nov; 75(11):1364-1374. PubMed ID: 30039165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of long-term outcome after intravenous or intra-arterial recombinant tissue plasminogen activator treatment in the eastern Hungarian thrombolysis database.
    Fekete K; Márton S; Tóth J; Csiba L; Fekete I; Bereczki D
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):117-24. PubMed ID: 25440339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.